149 related articles for article (PubMed ID: 10096547)
1. Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells.
Codony-Servat J; Albanell J; Lopez-Talavera JC; Arribas J; Baselga J
Cancer Res; 1999 Mar; 59(6):1196-201. PubMed ID: 10096547
[TBL] [Abstract][Full Text] [Related]
2. Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells.
Molina MA; Codony-Servat J; Albanell J; Rojo F; Arribas J; Baselga J
Cancer Res; 2001 Jun; 61(12):4744-9. PubMed ID: 11406546
[TBL] [Abstract][Full Text] [Related]
3. NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer.
Christianson TA; Doherty JK; Lin YJ; Ramsey EE; Holmes R; Keenan EJ; Clinton GM
Cancer Res; 1998 Nov; 58(22):5123-9. PubMed ID: 9823322
[TBL] [Abstract][Full Text] [Related]
4. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor.
Müllberg J; Durie FH; Otten-Evans C; Alderson MR; Rose-John S; Cosman D; Black RA; Mohler KM
J Immunol; 1995 Dec; 155(11):5198-205. PubMed ID: 7594530
[TBL] [Abstract][Full Text] [Related]
5. Synergistic inhibition with a dual epidermal growth factor receptor/HER-2/neu tyrosine kinase inhibitor and a disintegrin and metalloprotease inhibitor.
Witters L; Scherle P; Friedman S; Fridman J; Caulder E; Newton R; Lipton A
Cancer Res; 2008 Sep; 68(17):7083-9. PubMed ID: 18757423
[TBL] [Abstract][Full Text] [Related]
6. Synthetic matrix metalloproteinase inhibitors and tissue inhibitor of metalloproteinase (TIMP)-2, but not TIMP-1, inhibit shedding of tumor necrosis factor-alpha receptors in a human colon adenocarcinoma (Colo 205) cell line.
Lombard MA; Wallace TL; Kubicek MF; Petzold GL; Mitchell MA; Hendges SK; Wilks JW
Cancer Res; 1998 Sep; 58(17):4001-7. PubMed ID: 9731514
[TBL] [Abstract][Full Text] [Related]
7. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration.
Okamoto I; Kawano Y; Tsuiki H; Sasaki J; Nakao M; Matsumoto M; Suga M; Ando M; Nakajima M; Saya H
Oncogene; 1999 Feb; 18(7):1435-46. PubMed ID: 10050880
[TBL] [Abstract][Full Text] [Related]
8. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation.
Aigner A; Juhl H; Malerczyk C; Tkybusch A; Benz CC; Czubayko F
Oncogene; 2001 Apr; 20(17):2101-11. PubMed ID: 11360194
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphorylation and proteolysis. Pervanadate-induced, metalloprotease-dependent cleavage of the ErbB-4 receptor and amphiregulin.
Vecchi M; Rudolph-Owen LA; Brown CL; Dempsey PJ; Carpenter G
J Biol Chem; 1998 Aug; 273(32):20589-95. PubMed ID: 9685416
[TBL] [Abstract][Full Text] [Related]
10. Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells.
Perez-Torres M; Valle BL; Maihle NJ; Negron-Vega L; Nieves-Alicea R; Cora EM
Exp Cell Res; 2008 Oct; 314(16):2907-18. PubMed ID: 18687326
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme secretase is inhibited by zinc metalloprotease inhibitors and requires its substrate to be inserted in a lipid bilayer.
Parvathy S; Oppong SY; Karran EH; Buckle DR; Turner AJ; Hooper NM
Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):37-43. PubMed ID: 9355732
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer.
Kurokawa H; Arteaga CL
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4436s-4442s; discussion 4411s-4412s. PubMed ID: 11916237
[TBL] [Abstract][Full Text] [Related]
14. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
15. Silk fibroin mediated delivery of liposomal emodin to breast cancer cells.
Cheema SK; Gobin AS; Rhea R; Lopez-Berestein G; Newman RA; Mathur AB
Int J Pharm; 2007 Aug; 341(1-2):221-9. PubMed ID: 17499461
[TBL] [Abstract][Full Text] [Related]
16. Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors.
Sanderson MP; Dempsey PJ; Dunbar AJ
Growth Factors; 2006 Jun; 24(2):121-36. PubMed ID: 16801132
[TBL] [Abstract][Full Text] [Related]
17. Leptin augments proliferation of breast cancer cells via transactivation of HER2.
Soma D; Kitayama J; Yamashita H; Miyato H; Ishikawa M; Nagawa H
J Surg Res; 2008 Sep; 149(1):9-14. PubMed ID: 18262553
[TBL] [Abstract][Full Text] [Related]
18. Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells.
Youngren JF; Gable K; Penaranda C; Maddux BA; Zavodovskaya M; Lobo M; Campbell M; Kerner J; Goldfine ID
Breast Cancer Res Treat; 2005 Nov; 94(1):37-46. PubMed ID: 16142439
[TBL] [Abstract][Full Text] [Related]
19. Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors.
Kruse MN; Becker C; Lottaz D; Köhler D; Yiallouros I; Krell HW; Sterchi EE; Stöcker W
Biochem J; 2004 Mar; 378(Pt 2):383-9. PubMed ID: 14594449
[TBL] [Abstract][Full Text] [Related]
20. The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1.
Velasco-Loyden G; Arribas J; López-Casillas F
J Biol Chem; 2004 Feb; 279(9):7721-33. PubMed ID: 14672946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
